Difficult-to-treat axial spondyloarthritis patients

Objectives: This study aimed to formulate D2T (difficult to treat) criteria for axial spondyloarthritis (AxSpA) patients and identify the prevalence of D2T patients and their characteristics. Patients and methods: The cross-sectional study was conducted with 166 AxSpA patients (93 males, 73 females;...

Full description

Saved in:
Bibliographic Details
Published in:Archives of rheumatology 2024-09, Vol.39 (3), p.419-428
Main Authors: Ogut, Tahir Saygin, Erbasan, Funda, Sahiner, Mehmet Fatih, Nokay, Mine, Ogut, Ayse Yoruk, Dilbil, Melis, Terzioglu, Mustafa Ender, Yazisiz, Veli
Format: Article
Language:English
Subjects:
Adalimumab
Care and treatment
Fibromyalgia
Medical research
Medicine, Experimental
Original
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives: This study aimed to formulate D2T (difficult to treat) criteria for axial spondyloarthritis (AxSpA) patients and identify the prevalence of D2T patients and their characteristics. Patients and methods: The cross-sectional study was conducted with 166 AxSpA patients (93 males, 73 females; mean age: 47.1 [+ or -]12.9 years; range, 19 to 78 years) between February 2023 and March 2023. The criteria were based on patients treated according to the European Alliance of Associations for Rheumatology (EULAR) recommendations for AxSpA. Entry criteria were treatment failure to [greater than or equal to] 2 biological/targeted synthetic disease-modifying antirheumatic drugs with two different mechanisms of action or [greater than or equal to] 3 biological/targeted synthetic disease- modifying antirheumatic drugs. Potential preliminary factors for D2T criteria were analyzed, and the characteristics of the subjects matching D2T criteria were compared with those of others. Results: One hundred forty-two ankylosing spondylitis patients and 24 nonradiographic AxSpA patients were included in the study. The rate of fulfilling the D2T criteria was 22.9% (n=38) among AxsPA patients treated with biological agents. The potential D2T criteria were met by 23.2% of ankylosing spondylitis and 20.8% of nonradiographic AxSpA patients. Baseline characteristics, such as sex, age, diagnosis age, occupation, and education, of D2T patients were not statistically different from other patients. The prevalence of fibromyalgia was higher in D2T patients (p
ISSN:2148-5046
2618-6500
DOI:10.46497/ArchRheumatol.2024.10567